Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
Saved in:
| Title: | Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls. |
|---|---|
| Authors: | Zhao X; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Department of Statistics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Yang M; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China., Fan J; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China.; Health Management Center, Gusu School, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China., Wang M; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China., Wang Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China., Qin N; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Zhu M; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China.; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China., Jiang Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Gorlova OY; Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.; Department of Medicine, Epidemiology Section, Institute for Clinical and Translational Research, Baylor Medical College, Houston, Texas, USA., Gorlov IP; Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.; Department of Medicine, Epidemiology Section, Institute for Clinical and Translational Research, Baylor Medical College, Houston, Texas, USA., Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Lam S; Department of Integrative Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Tardón A; Department of Public Health IUOPA, University of Oviedo, ISPA and CIBERESP, Oviedo, Spain., Chen C; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Goodman GE; Public Health Sciences Division, Swedish Cancer Institute, Seattle, Washington, USA., Bojesen SE; Department of Clinical Biochemistry, Copenhagen University Hospital, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Landi MT; National Cancer Institute, Bethesda, Maryland, USA., Johansson M; Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France., Risch A; Department of Biosciences, Allergy-Cancer-BioNano Research Centre, University of Salzburg, Salzburg, Austria.; Division of Epigenomics and Cancer Risk Factors, DKFZ-German Cancer Research Center, Heidelberg, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany., Wichmann HE; Institute of Epidemiology, Helmholtz Center Munich, Neuherberg, Germany., Bickeböller H; Department of Genetic Epidemiology, University Medical Center Goettingen, Goettingen, Germany., Christiani DC; Departments of Environmental Health and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Rennert G; Technion Faculty of Medicine, Carmel Medical Center, Haifa, Israel., Arnold SM; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA., Brennan P; Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France., Field JK; Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool Institute of Translational Medicine, Liverpool, UK., Shete S; Department of Epidemiology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Le Marchand L; Epidemiology Program, University of Hawai'i Cancer Center, Honolulu, Hawaii, USA., Liu G; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Hung RJ; Prosseman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada., Andrew AS; Department of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands., Zienolddiny S; National Institute of Occupational Health (STAMI), Oslo, Norway., Grankvist K; Department of Medical Biosciences, Umeå University, Umea, Sweden., Johansson M; Department of Radiation Sciences, Umeå University, Umea, Sweden., Caporaso NE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA., Woll PJ; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK., Lazarus P; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA., Schabath MB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Aldrich MC; Department of Medicine (Division of Genetic Medicine), Vanderbilt University Medical Center, Nashville, Tennessee, USA., Patel AV; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia, USA., Davies MPA; Institute of Translational Medicine, University of Liverpool, Liverpool, UK., Ma H; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Jin G; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Hu Z; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Amos CI; Baylor College of Medicine, Institute for Clinical and Translational Research, Houston, Texas, USA., Shen H; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Dai J; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China. |
| Source: | Cancer [Cancer] 2024 Mar 15; Vol. 130 (6), pp. 913-926. Date of Electronic Publication: 2023 Dec 06. |
| Publication Type: | Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
